Skip to main content
Thorax logoLink to Thorax
. 1997 Jul;52(7):605–607. doi: 10.1136/thx.52.7.605

Is asthma treatment affordable in developing countries?

J P Watson, R A Lewis
PMCID: PMC1758612  PMID: 9246130

Abstract

BACKGROUND: A study was undertaken to assess whether the therapeutic aspects of published international asthma management guidelines are practically applicable in developing countries. METHODS: Questionnaires were sent to expatriate doctors working in developing countries. RESULTS: Forty one replies were received from 24 countries in Africa and Asia. Oral salbutamol was prescribed "usually" or "often" by 35 of the 41 respondents, theophyllines by 30, inhaled bronchodilators by 12, inhaled steroids by two, and cromoglycate by two. Theophyllines were locally available in all 41 cases, oral salbutamol in 40, inhaled bronchodilators in 34, and inhaled steroids (usually beclomethasone 50 micrograms) in only 15. Where they were available, the median (range) coat of a beclomethasone 50 micrograms inhaler was 20% (6.8-100%) of average local monthly income, salbutamol inhaler 13% (3.3-250%), 90 salbutamol 4 mg tablets 3.8% (0.8-75%), and 90 aminophylline 100 mg tablets 4.5% (0.5-70%). If they were available locally at a cheaper price, 34 (83%) respondents would prescribe more inhaled steroids and 37 (90%) would prescribe more inhaled bronchodilators. CONCLUSIONS: Many asthma patients in developing countries are not receiving adequate treatment because the required drugs are not available in their area or are prohibitively expensive. 




Full Text

The Full Text of this article is available as a PDF (99.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bedi R. S. Asthma management by private general practitioners of Punjab. Indian J Chest Dis Allied Sci. 1994 Jan-Mar;36(1):9–13. [PubMed] [Google Scholar]
  2. Cookson J. B. Prevalence rates of asthma in developing countries and their comparison with those in Europe and North America. Chest. 1987 Jun;91(6 Suppl):97S–103S. doi: 10.1378/chest.91.6_supplement.97s. [DOI] [PubMed] [Google Scholar]
  3. Murray J. F., Enarson D. A. World lung health: a concept that should become a reality. The ATS Committee on World Lung Health. Am Rev Respir Dis. 1992 Oct;146(4):818–822. doi: 10.1164/ajrccm/146.4.818. [DOI] [PubMed] [Google Scholar]
  4. Perera B. J. Efficacy and cost effectiveness of inhaled steroids in asthma in a developing country. Arch Dis Child. 1995 Apr;72(4):312–316. doi: 10.1136/adc.72.4.312. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Teklu B. Bronchial asthma at high altitude: a clinical and laboratory study in Addis Ababa. Thorax. 1989 Jul;44(7):586–587. doi: 10.1136/thx.44.7.586. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Warrell D. A., Fawcett I. W., Harrison B. D., Agamah A. J., Ibu J. O., Pope H. M., Maberly D. J. Bronchial asthma in the Nigerian savanna region. A clinical and laboratory study of 106 patients with a review of the literature on asthma in the tropics. Q J Med. 1975 Apr;44(174):325–347. [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES